Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

SpO2 Verification Study - Philips Nasal Alar With Nellcor OxiMax SpO2 Board (453564624031)

NCT07680530 is registered in ClinicalTrials.gov with Philips Clinical & Medical Affairs Global as lead sponsor.

NCT NCT07680530
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07680530 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
SpO2 Verification Study - Philips Nasal Alar With Nellcor OxiMax SpO2 Board (453564624031)
Lead sponsor
Philips Clinical & Medical Affairs Global
Phase
Observational
Overall status
Completed
Start date
May 28, 2026
Completion date
June 29, 2026
Enrollment
43 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pulse oximetry